Trials / Not Yet Recruiting
Not Yet RecruitingNCT04168346
Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 202 (estimated)
- Sponsor
- Helsinki University Central Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this investigator initiated study is to study if preoperative intravenous iron is effective in reducing need for allogenic blood transfusion in patients with gastric cancer who will undergo a standardized gastrectomy including both total and subtotal gastrectomies. The hypothesis is that intravenous iron reduces the need for perioperative blood transfusions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferric carboxymaltose | Ferric carboxymaltose iv infusion |
| DRUG | Placebos | NaCl 0.9% infusion |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2021-11-01
- Completion
- 2026-11-01
- First posted
- 2019-11-19
- Last updated
- 2019-11-19
Source: ClinicalTrials.gov record NCT04168346. Inclusion in this directory is not an endorsement.